Price T Rowe Associates Inc Morphic Holding, Inc. Transaction History

Price T Rowe Associates Inc

$836 Billion
Q2 2024

A detailed history of Price T Rowe Associates Inc transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 2,207,187 shares of MORF stock, worth $126 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,207,187

Previous 2,523,586 12.54%

Holding current value

$126 Million

Previous $88.8 Million 15.34%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$26.12 - $34.07 $8.26 Million - $10.8 Million	-316,399 Reduced 12.54%	2,207,187 $75.2 Million
Q1 2024 May 15, 2024	BUY	$26.64 - $40.31 $8.02 Million - $12.1 Million	300,958 Added 13.54%	2,523,586 $88.8 Million
Q4 2023 Feb 14, 2024	BUY	$19.95 - $31.0 $2.83 Million - $4.4 Million	141,888 Added 6.82%	2,222,628 $64.2 Million
Q3 2023 Nov 14, 2023	SELL	$21.33 - $59.42 $2.38 Million - $6.63 Million	-111,645 Reduced 5.09%	2,080,740 $47.7 Million
Q2 2023 Aug 14, 2023	BUY	$34.33 - $62.11 $24.1 Million - $43.6 Million	702,624 Added 47.16%	2,192,385 $126 Million
Q1 2023 May 15, 2023	BUY	$26.01 - $48.69 $9.36 Million - $17.5 Million	359,764 Added 31.84%	1,489,761 $56.1 Million
Q4 2022 Feb 14, 2023	SELL	$24.14 - $30.37 $235,896 - $296,775	-9,772 Reduced 0.86%	1,129,997 $30.2 Million
Q3 2022 Nov 14, 2022	SELL	$22.23 - $33.37 $2.42 Million - $3.63 Million	-108,791 Reduced 8.71%	1,139,769 $32.3 Million
Q2 2022 Aug 15, 2022	BUY	$19.74 - $43.01 $2.68 Million - $5.85 Million	135,909 Added 12.21%	1,248,560 $27.1 Million
Q1 2022 May 16, 2022	SELL	$36.25 - $52.02 $1.22 Million - $1.75 Million	-33,710 Reduced 2.94%	1,112,651 $44.7 Million
Q4 2021 Feb 14, 2022	BUY	$43.27 - $65.72 $5.46 Million - $8.29 Million	126,142 Added 12.36%	1,146,361 $54.3 Million
Q3 2021 Nov 15, 2021	BUY	$53.61 - $67.5 $34.7 Million - $43.7 Million	646,868 Added 173.26%	1,020,219 $57.8 Million
Q2 2021 Aug 16, 2021	BUY	$45.13 - $64.99 $128,349 - $184,831	2,844 Added 0.77%	373,351 $21.4 Million
Q1 2021 May 17, 2021	BUY	$29.77 - $84.85 $11 Million - $31.4 Million	370,507 New	370,507 $23.4 Million

Others Institutions Holding MORF

# of Institutions

118

Shares Held

38.1M

Call Options Held

4.2K

Put Options Held

200K

View Full List

About Morphic Holding, Inc.

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

More about MORF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Morphic Holding, Inc. Transaction History